Profile data is unavailable for this security.
About the company
Alzinova AB is a Sweden-based company, which is primarily involved in the biotechnology industry. The Company is engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease. The Company focuses on development of a specific oligomer-directed vaccine (ALZ-101), as well as on the development of diagnostics based on a monoclonal antibody (ALZ-201). Both products are specifically directed towards the form of oligomeric Aβ that damages brain synapses.
- Revenue in SEK (TTM)205.00k
- Net income in SEK-26.88m
- Incorporated2011
- Employees5.00
- LocationAlzinova ABAstraZeneca BioVentureHubPepparedsleden 1MOELNDAL 431 83SwedenSWE
- Phone+46 317865163
- Websitehttps://www.alzinova.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Spago Nanomedical AB (publ) | 437.00k | -26.55m | 79.39m | 7.00 | -- | 2.58 | -- | 181.67 | -0.0513 | -0.0513 | 0.0008 | 0.0465 | 0.0115 | -- | 4.39 | 62,428.57 | -69.64 | -30.44 | -81.41 | -32.48 | -- | -- | -6,076.43 | -3,410.33 | -- | -- | -- | -- | -77.13 | 5.02 | 18.32 | -- | -- | -- |
| IDL Diagnostics AB (publ) | 52.19m | -39.31m | 85.00m | 22.00 | -- | 0.5681 | -- | 1.63 | -0.1706 | -0.1706 | 0.2266 | 0.6495 | 0.3263 | 6.59 | 5.26 | 2,372,364.00 | -24.58 | -29.04 | -26.98 | -31.14 | 21.53 | 1.70 | -75.32 | -157.60 | 3.29 | -- | 0.0843 | -- | 33.45 | 164.62 | 28.41 | -- | 18.85 | -- |
| Alligator Bioscience AB | 42.25m | -77.72m | 95.14m | 13.00 | -- | -- | -- | 2.25 | -2.16 | -2.16 | 0.6369 | -0.0592 | 0.5013 | -- | 9.35 | 938,822.30 | -92.22 | -97.96 | -- | -155.50 | -- | -- | -183.96 | -569.04 | -- | -- | 1.33 | -- | -0.5851 | 67.68 | 5.91 | -- | -- | -- |
| Coegin Pharma AB | 0.00 | -20.64m | 99.01m | 3.00 | -- | 8.50 | -- | -- | -0.7859 | -0.7859 | 0.00 | 0.4681 | 0.00 | -- | -- | 0.00 | -85.07 | -133.34 | -91.51 | -179.59 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 15.00 | -- | -- | -- |
| Annexin Pharmaceuticals AB (publ) | 0.00 | -36.89m | 100.95m | 4.00 | -- | 4.05 | -- | -- | -5.98 | -5.98 | 0.00 | 3.53 | 0.00 | -- | -- | 0.00 | -150.00 | -137.53 | -190.93 | -169.50 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 26.58 | -- | -- | -- |
| Biosergen AB | 0.00 | -40.82m | 102.38m | 1.00 | -- | -- | -- | -- | -17.68 | -17.68 | 0.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -112.64 | -- | -- | -- |
| Active Biotech AB publ | 0.00 | -38.50m | 103.60m | 5.00 | -- | 13.54 | -- | -- | -0.0737 | -0.0737 | 0.00 | 0.0029 | 0.00 | -- | -- | 0.00 | -241.37 | -94.38 | -927.66 | -120.44 | -- | -- | -- | -3,355.24 | -- | -- | 0.0816 | -- | -- | -- | 13.98 | -- | -- | -- |
| Biovica International AB | 9.86m | -76.47m | 110.39m | 24.00 | -- | 0.9455 | -- | 11.19 | -0.6375 | -0.6375 | 0.0684 | 0.4241 | 0.0799 | 12.71 | 4.46 | 365,333.30 | -61.92 | -58.22 | -70.41 | -66.49 | -171.53 | -462.09 | -775.22 | -1,804.16 | 8.11 | -- | 0.0239 | -- | 18.23 | 38.83 | 29.80 | -- | -47.26 | -- |
| Glycorex Transplantation AB (publ) | 39.94m | -7.06m | 112.25m | 20.00 | -- | 3.15 | 47.70 | 2.81 | -0.0917 | -0.0917 | 0.5174 | 0.4719 | 0.7442 | 1.45 | 5.20 | 1,997,000.00 | -13.15 | -15.79 | -17.51 | -18.66 | 81.68 | 87.06 | -17.67 | -44.85 | 1.56 | -15.83 | 0.1599 | -- | 17.35 | -0.5296 | 63.97 | -- | -- | -- |
| Exact Therapeutics AS | 0.00 | -67.82m | 115.88m | 12.00 | -- | 1.82 | -- | -- | -1.40 | -1.40 | 0.00 | 1.07 | 0.00 | -- | -- | 0.00 | -108.82 | -43.50 | -168.39 | -50.76 | -- | -- | -- | -- | -- | -20.18 | 0.0052 | -- | -- | -- | -8.27 | -- | 1.47 | -- |
| Abera Bioscience AB | 0.00 | -10.45m | 116.44m | 5.00 | -- | 6.04 | -- | -- | -0.5692 | -0.5692 | 0.00 | 1.04 | 0.00 | -- | -- | -- | -49.58 | -63.36 | -74.82 | -81.05 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -850.27 | -- | -- | -- |
| Alzinova AB | 205.00k | -26.88m | 122.02m | 5.00 | -- | 0.5965 | -- | 595.20 | -0.2846 | -0.2846 | 0.0022 | 1.23 | 0.0015 | -- | 0.3254 | 41,000.00 | -19.42 | -12.21 | -20.69 | -12.85 | -5,834.15 | -- | -13,114.15 | -21,390.81 | -- | -1,794.80 | 0.0062 | -- | -88.89 | -- | -24.71 | -- | 19.48 | -- |
| SoftOx Solutions AS | 12.76m | -2.82m | 136.35m | 5.00 | -- | 1.34 | 180.23 | 10.68 | -0.001 | -0.001 | 0.0065 | 0.0445 | 0.123 | -- | 30.13 | 2,717,798.00 | -2.72 | -50.91 | -3.22 | -67.07 | -- | -- | -22.07 | -644.92 | 1.16 | -3.92 | 0.1212 | -- | 13.38 | 14.06 | -8.86 | -- | -- | -- |
| NextCell Pharma AB | 10.94m | -35.14m | 159.96m | 24.00 | -- | 2.41 | -- | 14.63 | -0.4414 | -0.4414 | 0.133 | 0.596 | 0.1384 | 51.23 | 4.68 | -- | -44.48 | -34.95 | -49.25 | -37.53 | -155.37 | -266.34 | -321.31 | -427.08 | 9.92 | -- | -- | -- | 2.56 | 25.13 | 16.25 | -- | 36.88 | -- |
| ViroGates A/S | 7.15m | -17.56m | 161.89m | 7.00 | -- | 33.56 | -- | 22.65 | -1.63 | -1.63 | 0.6609 | 0.3665 | 0.3568 | 0.9777 | 4.41 | 504,300.00 | -87.63 | -54.92 | -131.36 | -63.15 | 47.33 | 72.98 | -245.63 | -215.48 | 1.58 | -16.13 | 0.6277 | -- | -12.27 | 6.45 | -18.59 | -- | -- | -- |
| SenzaGen AB | 57.88m | -16.18m | 164.63m | 37.00 | -- | 2.22 | -- | 2.84 | -0.5483 | -0.5483 | 1.96 | 2.52 | 0.5577 | 5.47 | 6.63 | 1,702,294.00 | -15.59 | -20.91 | -18.89 | -25.17 | 65.09 | 67.10 | -27.95 | -71.43 | 2.73 | -- | 0.0707 | -- | 15.69 | 84.16 | 19.22 | -- | -1.18 | -- |
Data as of Feb 13 2026. Currency figures normalised to Alzinova AB's reporting currency: Swedish Krona SEK
